je.st
news
Celgene says Otezla falls short in added use study
2014-07-09 16:17:52| Biotech - Topix.net
Shares of Celgene Corp. slipped in premarket trading Wednesday after the drugmaker said its psoriatic arthritis treatment Otezla missed the main goal of a late-stage study exploring an additional use.
Tags: use
added
short
study
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||